Literature DB >> 27599716

Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.

Dah Ihm Kim1, Ki Hoon Lee2, Amr Ahmed Gabr3, Gee Euhn Choi4, Jun Sung Kim5, So Hee Ko6, Ho Jae Han7.   

Abstract

Mitochondrial dysfunction is known as one of causative factors in Alzheimer's disease (AD), inducing neuronal cell death. Mitochondria regulate their functions through changing their morphology. The present work was undertaken to investigate whether Amyloid β (Aβ) affects mitochondrial morphology in neuronal cells to induce apoptosis. Aβ treatment induced not only the fragmentation of mitochondria but also neuronal apoptosis in association with an increase in caspase-9 and -3 activity. Calcium influx induced by Aβ up-regulated the activation of Akt through CaMKII resulting in changes to the phosphorylation level of Drp1 in a time-dependent manner. Translocation of Drp1 from the cytosol to mitochondria was blocked by CB-124005 (an Akt inhibitor). Recruitment of Drp1 to mitochondria led to ROS generation and mitochondrial fission, accompanied by dysfunction of mitochondria such as loss of membrane potential and ATP production. ROS generation and mitochondrial dysfunction by Aβ were attenuated when treated with Mdivi-1, a selective Drp1 inhibitor. Furthermore, the sustained Akt activation induced not only the fragmentation of mitochondria but also the activation of mTOR, eventually suppressing autophagy. Inhibition of autophagic clearance of Aβ led to increased ROS levels and aggravating mitochondrial defects, which were blocked by Rapamycin (an mTOR inhibitor). In conclusion, sustained phosphorylation of Akt by Aβ directly activates Drp1 and inhibits autophagy through the mTOR pathway. Together, these changes elicit abundant mitochondrial fragmentation resulting in ROS-mediated neuronal apoptosis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Akt; Amyloid β (Aβ); Autophagy; Drp1; Mitochondrial dynamics; ROS

Mesh:

Substances:

Year:  2016        PMID: 27599716     DOI: 10.1016/j.bbamcr.2016.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

Review 1.  Mitochondrial dynamics and their potential as a therapeutic target.

Authors:  B N Whitley; E A Engelhart; S Hoppins
Journal:  Mitochondrion       Date:  2019-06-19       Impact factor: 4.160

Review 2.  To mdivi-1 or not to mdivi-1: Is that the question?

Authors:  George Smith; Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2017-08-30       Impact factor: 3.964

Review 3.  Relationship Between β-Amyloid and Mitochondrial Dynamics.

Authors:  Dah Ihm Kim; Ki Hoon Lee; Ji Young Oh; Jun Sung Kim; Ho Jae Han
Journal:  Cell Mol Neurobiol       Date:  2016-10-20       Impact factor: 5.046

4.  TRAK1-Mediated Abnormality of Mitochondrial Fission Increases Seizure Susceptibility in Temporal Lobe Epilepsy.

Authors:  Hao Wu; Yong Liu; Huanfa Li; Changwang Du; Kuo Li; Shan Dong; Qiang Meng; Hua Zhang
Journal:  Mol Neurobiol       Date:  2020-10-29       Impact factor: 5.590

5.  Long-Term Potentiation Requires a Rapid Burst of Dendritic Mitochondrial Fission during Induction.

Authors:  Sai Sachin Divakaruni; Adam M Van Dyke; Ramesh Chandra; Tara A LeGates; Minerva Contreras; Poorna A Dharmasri; Henry N Higgs; Mary Kay Lobo; Scott M Thompson; Thomas A Blanpied
Journal:  Neuron       Date:  2018-10-11       Impact factor: 17.173

Review 6.  Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.

Authors:  Vivek Kumar Sharma; Thakur Gurjeet Singh; Shareen Singh; Nikhil Garg; Sonia Dhiman
Journal:  Neurochem Res       Date:  2021-08-12       Impact factor: 3.996

7.  Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction In Vitro: Implication for a Potential Therapy of Alzheimer's Disease.

Authors:  Dan Cheng; Xin-Jing Yang; Lu Zhang; Zong-Shi Qin; Wen-Qi Li; Hai-Chun Xu; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 8.  mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.

Authors:  M Perluigi; F Di Domenico; E Barone; D A Butterfield
Journal:  Free Radic Biol Med       Date:  2021-04-30       Impact factor: 8.101

Review 9.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

Review 10.  Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases.

Authors:  Amit U Joshi; Daria Mochly-Rosen
Journal:  Pharmacol Res       Date:  2018-08-23       Impact factor: 10.334

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.